Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2002
05/02/2002CA2426286A1 Method for detecting ovarian cancer based on human kallikrein 6 (hk6)
05/02/2002CA2425904A1 Materials and methods relating to nucleic acid amplification and profiling
05/02/2002CA2425897A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/01/2002CN1347501A Method of diagnosing transmissible spongiform encephalopathies
05/01/2002CN1347500A Measurement and use of molecular interactions
05/01/2002CN1347460A Monolayer and electrode for detecting label-bearing target and method of use thereof
05/01/2002CN1347283A eNOS mutations useful for gene therapy and therapeutic screening
05/01/2002CN1346983A Process for preparing biologic sensor by embedding enzyme with composite titanium oxide sol-gel membrane
05/01/2002CN1346893A Method of synchronous PCR detection of DNA and RNA pathogens with Tag enzyme
05/01/2002CN1346892A Biochip for joint detection of gastrosis
05/01/2002CN1083886C Oligosaccharide amino alditols and assay method
04/2002
04/30/2002US6380380 Use of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucliotide phosphate (NADP) analogs to measure enzyme activities metabolites and substrates
04/30/2002US6380377 Nucleic acid hairpin probes and uses thereof
04/30/2002US6380376 Purity polypeptides
04/30/2002US6380374 Isolated nucleic acid; culture product
04/30/2002US6380373 Isolated nucleic acid
04/30/2002US6380372 Barley gene for Thioredoxin and NADP-thioredoxin reductase
04/30/2002US6380370 Genetic sequence; nucleotide sequence
04/30/2002US6380368 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
04/30/2002US6380363 Antibodies to the Ob receptor
04/30/2002US6380360 Polycystic kidney disease 1 gene and uses thereof
04/30/2002US6380159 Genes for male accessory gland proteins in drosophila melanogaster
04/30/2002US6379970 Analysis of differential protein expression
04/30/2002US6379964 Forming a protoplasts population of different cells, fusing the protoplast and forming hybrids that are then incubated to promote cell regeneration; regenerated cells are then screened based on desired properties
04/30/2002US6379957 A mutation detection method by combining double stranded nucleic acid templates derived from specific viral primers; amplify templates to produce sequenceing products, separate and analyze the nucleic acid; detect drug resistance
04/30/2002US6379950 Recombinant, active caspases and uses thereof
04/30/2002US6379942 Chemically modified enzymes with multiple charged variants
04/30/2002US6379932 Amplifying rna by hydridizing and extending with a first primer to form cdna strand; then hybridize/amplify cdna with second primer; then amplifying second cdna with a third primer comprising of the first amplified sequence
04/30/2002US6379930 Reagents necessary to perform nucleic acid amplification are encapsulated in liposome vesicles; prevents undesirable side reactions
04/30/2002US6379929 Chip-based isothermal amplification devices and methods
04/30/2002US6379920 An otitis media detection method by obtainins a spectra sample of a non-infected patient to be used as a reference to be subtracted from the infected sample spectra
04/30/2002US6379918 Composition, formulae, devices and methods for control of specificity and inclusivity of microorganisms containing closely related antigen epitopes
04/30/2002US6379917 An apparatus for automatically measuring effects of a test compound on cells; having a test compound sampler, a cell suspension input for supplying homogenous cell suspensions, a mixing zone coupled to the sampler and a detector
04/30/2002US6379915 Diagnostic compositions and devices utilizing same
04/30/2002US6379914 Method and apparatus for measuring use of a substrate in a microbially catalyzed reaction
04/30/2002US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease
04/30/2002US6379912 Motor proteins and method for their use
04/30/2002US6379911 Analyzing nucleoside hydrolases; detecting parasites
04/30/2002US6379907 Detecting cancerous cervical lesions from atypical glandular cells of undetermined significance papanicolaou smear cells based on the presence of a specific antigen not found in atypical cells, but present on normal endocervical cells
04/30/2002US6379899 Isothermal exponential RNA amplification in complex mixtures
04/30/2002US6379898 Nucleic acid detection
04/30/2002US6379897 Methods for gene expression monitoring on electronic microarrays
04/30/2002US6379896 Probes for variance detection
04/30/2002US6379895 Photolithographic and other means for manufacturing arrays
04/30/2002US6379894 Method for screening compounds capable of inhibiting binding between the transcription factor of STAT1 and the transcription factor of USF1
04/30/2002US6379892 A nucleotide sequence; diagnosis of chlamydia infections
04/30/2002US6379891 A polymerase chain reaction amplification method for detecting enterically transmitted non-a/non-b viral hepatitis in a biological sample
04/30/2002US6379890 Method for determining asthma susceptibility
04/30/2002US6379889 Separating nucleic acid samples from a test mixture by labelling each sample with a spectrally detectable tag; applying the mixture to a reversed phase support; eluting the mixture under denaturing conditions and detect the signal
04/30/2002US6379888 A method using a signal primer that is partially single and double stranded; in the presence of a target, strand displacement occurs causing a conformational change in a reporter probe and quenches the fluorecent signal
04/30/2002US6379887 A polynucleotide; used in cosmetic and dermatology development
04/30/2002US6379886 Diagnostic regeant for hepatitis C virus infection
04/30/2002US6379884 Detecting preferential cellular activty in sample; provide cells and binding particles, incubate, determine amount of binding within cells by measuring polarized fluorescent light in cell
04/30/2002US6379883 Microfabricated aperture-based sensor
04/30/2002US6379881 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus
04/30/2002US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety
04/30/2002US6379671 Using a polypeptide antigen mixture
04/30/2002US6379665 Therapy for rheumatic diseases; antiarthritic agents
04/30/2002CA2360049A1 Assays for identifying phosphatase inhibitors
04/30/2002CA2151045C Platelet-activating factor acetylhydrolase
04/30/2002CA2082050C Ultrasensitive microtrace procedure for monitoring the origin movement and fate of any liquid or solid material
04/25/2002WO2002033638A2 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
04/25/2002WO2002033420A2 A urine test for the diagnosis of prion diseases
04/25/2002WO2002033416A1 Assays
04/25/2002WO2002033409A1 Support for immobilizing nucleic acid
04/25/2002WO2002033402A2 Establishment of biological cut-off values for predicting resistance to therapy
04/25/2002WO2002033129A2 Nucleic acid amplification controls
04/25/2002WO2002033128A2 Multiplex quantification of nucleic acids in diseased cells
04/25/2002WO2002033126A2 Solid support assay systems and methods utilizing non-standard bases
04/25/2002WO2002033125A1 Nucleic acid detection by dendrimeric labeling
04/25/2002WO2002033123A1 Arrays of oligonucleotide probes for digital recognition by computer
04/25/2002WO2002033122A1 Method of examining allergic diseases
04/25/2002WO2002033121A2 Test for the diagnosis of diabetes and compounds for the treatment thereof
04/25/2002WO2002033120A2 Non-invasive prenatal monitoring
04/25/2002WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
04/25/2002WO2002033118A2 Isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection
04/25/2002WO2002033117A2 Method for tandem genomic/proteomic analyses of proliferating cells
04/25/2002WO2002033116A2 Nucleic acid ligands to the prostate specific membrane antigen
04/25/2002WO2002033114A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033113A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033112A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033100A2 Regulation of human adenylate cyclase, type iv
04/25/2002WO2002033099A2 Human kinases
04/25/2002WO2002033095A2 Regulation of human serine-threonine protein kinase
04/25/2002WO2002033086A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/25/2002WO2002033084A2 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
04/25/2002WO2002033079A2 Human g-protein coupled receptor and uses thereof
04/25/2002WO2002033069A1 Method of examining allergic disease
04/25/2002WO2002033068A1 Method of analyzing nucleic acid base sequence
04/25/2002WO2002033063A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
04/25/2002WO2002033049A1 Human tuberoinfundibular peptide of 39 residues
04/25/2002WO2002033046A2 Glucose transport-related genes and uses thereof
04/25/2002WO2002033044A2 Methods of high-throughput screening for internalizing antibodies
04/25/2002WO2002032961A2 Novel polypeptides and nucleic acids encoding same
04/25/2002WO2002032960A2 Methods of selecting compounds for modulation of bladder function
04/25/2002WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
04/25/2002WO2002032955A1 Human gene critical to fertility
04/25/2002WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2)
04/25/2002WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
04/25/2002WO2002032937A2 Neuromedin u delta